First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice.

ABSTRACT:

SUBMITTER: Naito R 

PROVIDER: S-EPMC7354318 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature